| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702539 | Urologic Oncology: Seminars and Original Investigations | 2017 | 7 Pages |
Abstract
Serial retrograde instillations of MitoGel to the pyelocaliceal system were technically feasible, and produced no observable adverse clinical, laboratory, or histologic effects.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Nicholas M. MD, Dalit DVM, PhD, Yael DVM, PhD, Nadav Malchi, Andrew T. MD, MS, Stuart MD, Allan J. MD, MS, Arie S. MD, Karim MD, MSHS,